These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 16673610)

  • 1. Severity of liver echogenicity is correlated to serum c-peptide levels in type 2 diabetic patients.
    Papanas N; Symeonidis G; Mavridis G; Papazoglou D; Giannakis I; Papatheodorou K; Pastore F; Lakasas G; Maltezos E
    Acta Clin Belg; 2006; 61(1):5-9. PubMed ID: 16673610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
    Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
    Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-peptide response to glucagon in patients with non-insulin-dependent diabetes mellitus.
    Juang JH; Huang HS; Huang MJ
    J Formos Med Assoc; 1992 May; 91(5):491-6. PubMed ID: 1358326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes.
    Albareda M; Rigla M; Rodríguez-Espinosa J; Caballero A; Chico A; Cabezas R; Carreras G; Pérez A
    Diabetes Res Clin Pract; 2005 Jun; 68(3):202-6. PubMed ID: 15936461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-peptide response to glucagon in young diabetics.
    Juang JH; Huang BY; Huang HS; Lin JD; Huang MJ
    Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):579-83. PubMed ID: 2677232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
    Amoah AG; Schuster DP; Gaillard T; Osei K
    Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are basal and glucagon-stimulated C-peptide values predictors of response to GLP-1 receptor agonists in type 2 diabetic patients?
    Maiza JC; Gérard P; Rollot O; Cogne M; Jarlet E; Schneebeli S
    Minerva Endocrinol; 2016 Mar; 41(1):138-40. PubMed ID: 26878563
    [No Abstract]   [Full Text] [Related]  

  • 8. Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area.
    Fujita Y; Kozawa J; Iwahashi H; Yoneda S; Uno S; Yoshikawa A; Okita K; Eguchi H; Nagano H; Imagawa A; Shimomura I
    Endocr J; 2015; 62(4):329-37. PubMed ID: 25740613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic reserve and insulin dose in type 2 diabetic patients.
    Calle JR; Rubio MA; Calle-Pascual AL; Bordiu E; Marañés JP
    Diabetes Res; 1993; 23(3):123-9. PubMed ID: 7712686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
    Amoah AG; Owusu SK; Schuster DP; Osei K
    S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta cell function in long term NIDDM (type 2) patients and its relation to treatment.
    Snehalatha C; Ramachandran A; Mohan V; Timothy H; Viswanathan M
    Horm Metab Res; 1986 Jun; 18(6):391-4. PubMed ID: 3525362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
    Miyazaki Y; DeFronzo RA
    Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of food on glycemia, insulin, C-peptide and glucagon levels in diabetic patients treated with antidiabetic metformin at steady-state.
    Cardot JM; Saffar F; Aiache JM
    Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):715-21. PubMed ID: 9542722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum leptin levels in female patients with NIDDM.
    Haque Z; Rahman MA
    J Coll Physicians Surg Pak; 2003 Mar; 13(3):130-4. PubMed ID: 12689528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta cell function and response to treatment in Nigerians with Type 2 diabetes mellitus.
    Oli JM; Adeyemo AA; Okafor GO; Ofoegbu EN; Onyenekwe B; Chukwuka CJ; Chen G; Chen Y; Doumatey AP; Aje TO; Rotimi CN
    Diabetes Res Clin Pract; 2005 Aug; 69(2):196-204. PubMed ID: 16005370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In which patients will performing an oral glucose tolerance test yield the highest rate of positive results?
    Uzunlulu M; Oguz A; Yorulmaz E
    Acta Clin Belg; 2006; 61(2):64-8. PubMed ID: 16792336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Random C-peptide in the classification of diabetes.
    Berger B; Stenström G; Sundkvist G
    Scand J Clin Lab Invest; 2000 Dec; 60(8):687-93. PubMed ID: 11218151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of C-peptide level measurements in diabetes mellitus.
    Rajasoorya C; Tan YT; Chew LS
    Ann Acad Med Singap; 1990 Jul; 19(4):463-6. PubMed ID: 2221804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating transition probability of different states of type 2 diabetes and its associated factors using Markov model.
    Nazari M; Hashemi Nazari S; Zayeri F; Gholampour Dehaki M; Akbarzadeh Baghban A
    Prim Care Diabetes; 2018 Jun; 12(3):245-253. PubMed ID: 29396206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.